Navigation Links
Measles Risk in Transplant Patients

People with a compromised immune system who have undergone organ transplantation could be at a high risk of measles if they don’t receive the measles, mumps and rubella vaccine in a timely manner.//

Completion of MMR vaccination in southeast London is among the lowest in the United Kingdom. Just over 60 percent of children aged 2 years received a first dose of the vaccine by March 2003. (Data shows there were 66 cases of measles reported in the second quarter of the year.) In a letter in this week’s issue of The Lancet, researchers describe how two children with kidney transplants developed complications from measles. Both children received a single dose of the MMR vaccine before transplantation, but since they were about 2 years old at the time, they were unable to have a preschool booster dose. The first dose of the vaccine is recommended at about 13 months old. The booster dose is then given between 3 and 5 years old.

Authors of the letter write, "The reappearance of measles in the community poses a severe threat to vulnerable immunocompromised individuals, including recipients of transplants. Without a substantial increase in the uptake of MMR vaccination, difficult challenges lie ahead. Measles is a notoriously infectious disease and will spread easily among those who are non-immune."

Researchers also say the two children in their report did not have typical presentations of measles and they caution researchers to be aware of this. They write, "Immunocompromised individuals may manifest only a non-specific illness without rash, which makes rapid diagnosis difficult and may delay measures to prevent further spread"
'"/>




Page: 1

Related medicine news :

1. Acute Measles Supresses HIV Replication
2. Measles Suppresses AIDS Virus
3. Drop in Worldwide Measles deaths by 40%
4. Measles Break Out In Relief Camps
5. Measles Vaccination Drive Intensified In Quake-Hit Pakistan
6. Measles Breaks Out In Kashmir
7. Measles Outbreak In Bihar Creates Panic
8. Death Due To Measles Plummet By About 50% Following WHO Campaign
9. Measles Resurges Due To Drop In Immunization With MMR
10. Staff Nurses Contract Measles from the Patient
11. Generous Donation by US Helps to Curb the Outbreak of Measles in Fiji
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Measles Risk Transplant Patients

(Date:7/8/2008)...s Innovation,s Proprietary,Device-Free Remote Mon...and Medical Costs, NO...vations, a pioneer,in assisting clients to achieve...e improvement through a device-free remote monitor... Iowa Medicaid Congestive Heart Failure,Population...
(Date:7/8/2008)... in cancer research, particularly in observational... misleading results can be mitigated if researcher...d reporting results, according to a commentary in ...ional Cancer Institute . Additionally, the impact ... researchers and other stakeholders, including jou...
(Date:7/8/2008)...to Lower Health Care Costs, Increase Access...RGH, July 8 /PRNewswire/ -- The chief executives o...fied here today at the first,Pennsylvania Insuranc...of,the two companies, saying that it will be good ...unities the two organizations serve -- and would n...
(Date:7/8/2008)...s , , TUESDAY, July 8 (HealthDay News) -...in the ankle and the arm can help improve assessme...cardiovascular problems, an international research... that it is extremely easy to perform and doesn,t ...Fowkes, a professor of epidemiology at the Univers...
Breaking Medicine News(10 mins):Health News:Iowa Medicaid Demonstration Finds Tel-Assurance(R) Remote Monitoring Platform Improved Health Status and Saved $5 Million 2Health News:Iowa Medicaid Demonstration Finds Tel-Assurance(R) Remote Monitoring Platform Improved Health Status and Saved $5 Million 3Health News:Awareness of epidemiology's limitations could reduce impact of false-positive cancer results 2Health News:Highmark and Independence Blue Cross CEOs Say Combination of Highmark and Independence Blue Cross will Provide $1 Billion in New Resources Over Six Years 2Health News:Ankle-Arm Blood Pressure Test Predicts Heart Disease Risk 2
...ld congress for diabetes begins in Chennai today. ...es and its complications //and over 1000 doctors a...ries across the world. The world congress for di...y three years, since the time of its inception in ...
... that looked at the fiber intake among kids shows ...getting enough fiber // in their diets thereby put...constipation and heart disease . Researchers analy...1994 and 1996 and in 1998, on dietary intake over ...
...n therapy is used to treat deep vein thrombosis, w...or arms. Researchers say several new studies show ...fy anticoagulation therapy.// In the first study,...mbosis) patients and compared the effectiveness an...
...ved of oxygen can have a reduced risk of brain dam...ed // for 72 hours after birth according to a rece...ly of oxygen to the brain during delivery showed s...njury. However researchers say brain damage does n...
Other Medicine News:
(Date:7/7/2008)...ment Presence Includes ANA598 and ANA773 Acting vi...ry Mechanisms Conference Call Tod...FirstCall/ -- Anadys Pharmaceuticals,Inc. (Nasdaq...ical,investigation of the Toll-Like Receptor-7 (TL...is C. Based on preclinical pharmacology testing,an...
(Date:7/7/2008)...RNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC,Bul...ded biopharmaceutical,company specializing in the ...oday provided an operational update on the company...human clinical trial testing and,plans to proceed ...e. Five,successful human trials evaluating GeoVax ...
(Date:7/7/2008)...gests Kiwifruit is Top Performer in the Body, SEA...eated equal when,it comes to their antioxidant pow... bioavailability compared to other antioxidant-ric... published in the Journal of the,American College ...phytochemicals called flavonoids that,may have the...
(Date:7/3/2008)...ly 3 /PRNewswire-USNewswire/ -- All newborn infant...hat is present at birth,according to a new recomm...rce. The recommendation and the accompanying summa...trics., Children whose hearing is impaired at bir...problems with verbal and nonverbal communication a...
Breaking Medicine Technology:Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 2Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 3Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 4Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 5GeoVax Reports Progress on Its AIDS Vaccine Technology 2GeoVax Reports Progress on Its AIDS Vaccine Technology 3GeoVax Reports Progress on Its AIDS Vaccine Technology 4GeoVax Reports Progress on Its AIDS Vaccine Technology 5Kiwifruit: Antioxidant Power in Quantity and Quality 2Task Force Recommends Screening for Hearing Loss in All Newborns 2Task Force Recommends Screening for Hearing Loss in All Newborns 3Response Genetics to Announce Third Quarter 2007 Financial Results on Wednesday November 14 2007 5924 1Response Genetics to Announce Third Quarter 2007 Financial Results on Wednesday November 14 2007 5924 25 000 Patients Treated With OrbusNeichs Genous 28TM 29 Bio engineered R Stent 28TM 29 Now Enrolled in Real Life Use Global Registry 5922 15 000 Patients Treated With OrbusNeichs Genous 28TM 29 Bio engineered R Stent 28TM 29 Now Enrolled in Real Life Use Global Registry 5922 2California Restaurant Association Chooses EMPLOYERS 28R 29 as its New Provider of Choice for Members Workers Compensation Insurance Needs 5920 1California Restaurant Association Chooses EMPLOYERS 28R 29 as its New Provider of Choice for Members Workers Compensation Insurance Needs 5920 2National physician organization supports Capps Rogers Bill at todays congressional briefing 5918 1National physician organization supports Capps Rogers Bill at todays congressional briefing 5918 2
...May 14, 2007 - Acceleron Pharma,Inc., a biopharma...reatment of musculoskeletal, metabolic and cancer-...clinical study with,ACE-031 that demonstrated the ...d strength in normal mice and in murine models of,...lators of muscle,to increase muscle mass and stren...
...rket dynamics offers insights into,what will be ne...ients, NEW YORK, May 14, 2007 /PRNewswire-USNewsir...(TB Alliance), a not-for-profit,product developme...lopment of new TB drugs, today released results fr...f the global TB drug market,that offers a detailed...
Other Medicine Technology:Acceleron Pharma's ACE-031 Increases Muscle Mass and Strength in,Preclinical Studies 2Acceleron Pharma's ACE-031 Increases Muscle Mass and Strength in,Preclinical Studies 3New Study Reveals Limitations of a Complex and Challenging Global,Tuberculosis Drug Marketplace 2New Study Reveals Limitations of a Complex and Challenging Global,Tuberculosis Drug Marketplace 3New Study Reveals Limitations of a Complex and Challenging Global,Tuberculosis Drug Marketplace 4
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
Medicine Products: